Royalty Pharma (RPRX)
Nasdaq • RPRX • GB00BMVP7Y09
ORTEX Data Highlights
ORTEX Data Highlights
As of Nov 3, 2026, ORTEX estimates 3.1% of free float is sold short, 3.9 days to cover, cost to borrow 0.4%.
Market Cap
29.6b USD | # 726 in US
Volume
3.08m shares | 185.41m USD
Shares Outstanding
445.28m
Free Float Shares
93.78% | 417.57m
